The results showed that anthracycline treatment increased Gal-9 protein levels in all tested cell lines, including MDA-MB-231 and BT549 human breast cancer cells, PY8119 and EMT6 murine breast cancer cells, and B16-F10 murine melanoma cells (Fig. 2A). Here, LGALS9 is linked to breast carcinoma.